- Price is above Fair Value, showing premium demand versus the model.
- Latest weekly return ranks in the strongest part of its sector group.
ALIMP
PAR
Week ended 07 Aug 2026
Weekly Investor Report
Implanet S.A. · Healthcare · Medical Devices
Latest close
0.18 EUR
8.4%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -10.8% below the Trend Line and sits at 8.1% of its 52-week range. The latest completed week returned 8.4%, after a 4.0% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
21
out of 100
Latest Close
0.18 EUR
7 Aug 2026
1W Return
8.4%
latest completed week
4W Return
4.0%
short-term follow-through
12W Return
-7.9%
quarterly tape
Trend Breadth
32.7%
17 of 52 weeks active
Volume Ratio
0.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 38.23% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
8.4%
Latest completed week; four-week move 4.0%.
Indicator stack
18/21
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 38.23%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -10.8% below the Trend Line and sits at 8.1% of its 52-week range. The latest completed week returned 8.4%, after a 4.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1212-week average 0.09
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.12Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 4.0% over four weeks, -7.9% over 12 weeks, and 5.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year17
Trend breadth32.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.64Latest activity-pressure read.
Pressure change11.3%Four-week change in activity pressure.
Leadership-23.83Latest relative-leadership reading.
RS change-0.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-60.3%Distance below the 52-week high.
13-week volatility4.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2615 weeks finished lower.
Best week+8.4%Week of 7 Aug.
Worst week-10.9%Week of 20 Feb.
Latest week+8.4%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains6
Flat weeks1
Modest losses9
Sharp losses6
Recent vol4.1%13-week weekly-return volatility.
Base vol11.9%52-week weekly-return volatility.
Up/down split25/26Count of positive and negative weeks in the 52-week window.
Average skew8.8% / -6.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFR Healthcare
4-week rank20 / 76
Group average0.7%
Trend breadth26.3%
Trend26.3%active weekly trend signals
MD40.8%positive activity pressure
RS19.7%positive relative leadership
Four-week leaders
IndustryFR Medical Devices
4-week rank3 / 13
Group average-5.4%
Trend breadth15.4%
Trend15.4%active weekly trend signals
MD15.4%positive activity pressure
RS15.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape17/100
Trend, activity pressure, participation, and risk combine to a 17/100 tape read.
Indicator analysis11/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.12; No reversal markers Next-Week ExpectancyNegative 38.23%Next-week expectancy is negative with a 38.23% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Implanet S.A. (ALIMP.PA) latest stock news and headlines Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.18 EUR | 8.4% | 0.20 EUR | 0.14 EUR | -1.64 | -23.83 | 119.7K | Off |
| 31 Jul 2026 | 0.17 EUR | -3.6% | 0.20 EUR | 0.14 EUR | -1.96 | -28.09 | 167.7K | Off |
| 24 Jul 2026 | 0.17 EUR | 0.1% | 0.20 EUR | 0.14 EUR | -1.91 | -24.31 | 123.9K | Off |
| 17 Jul 2026 | 0.17 EUR | -0.6% | 0.20 EUR | 0.14 EUR | -1.93 | -23.95 | 256.1K | Off |
| 10 Jul 2026 | 0.17 EUR | 1.1% | 0.21 EUR | 0.14 EUR | -1.85 | -23.75 | 693.5K | Off |
| 3 Jul 2026 | 0.17 EUR | 0.2% | 0.21 EUR | 0.14 EUR | -1.82 | -25.67 | 181.9K | Off |
| 26 Jun 2026 | 0.17 EUR | -8.2% | 0.21 EUR | 0.14 EUR | -1.72 | -24.39 | 129.3K | Off |
| 19 Jun 2026 | 0.18 EUR | -3.2% | 0.21 EUR | 0.14 EUR | -1.61 | -17.52 | 49.2K | Off |
| 12 Jun 2026 | 0.19 EUR | 0.0% | 0.21 EUR | 0.14 EUR | -1.58 | -13.47 | 35.9K | Off |
| 5 Jun 2026 | 0.19 EUR | 3.6% | 0.21 EUR | 0.14 EUR | -1.55 | -11.43 | 309.8K | Off |
| 29 May 2026 | 0.18 EUR | -2.2% | 0.21 EUR | 0.14 EUR | -1.66 | -13.43 | 413.1K | Off |
| 22 May 2026 | 0.19 EUR | -2.8% | 0.21 EUR | 0.14 EUR | -1.71 | -10.06 | 503.8K | Off |
| 15 May 2026 | 0.19 EUR | 5.5% | 0.22 EUR | 0.14 EUR | -1.63 | -4.86 | 331.6K | Off |
| 8 May 2026 | 0.18 EUR | -6.3% | 0.22 EUR | 0.14 EUR | -1.45 | -10.84 | 284.7K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.